BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22450871)

  • 1. Rhes: a GTP-binding protein integral to striatal physiology and pathology.
    Harrison LM
    Cell Mol Neurobiol; 2012 Aug; 32(6):907-18. PubMed ID: 22450871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes.
    Harrison LM; Lahoste GJ
    Exp Cell Res; 2013 Sep; 319(15):2310-5. PubMed ID: 23583659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhes: A striatal-specific Ras homolog related to Dexras1.
    Falk JD; Vargiu P; Foye PE; Usui H; Perez J; Danielson PE; Lerner DL; Bernal J; Sutcliffe JG
    J Neurosci Res; 1999 Sep; 57(6):782-8. PubMed ID: 10467249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
    Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
    Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase.
    Harrison LM; He Y
    J Neurosci Res; 2011 Jun; 89(6):874-82. PubMed ID: 21374700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models.
    Napolitano F; D'Angelo L; de Girolamo P; Avallone L; de Lange P; Usiello A
    Neuroscience; 2018 Aug; 384():419-428. PubMed ID: 29857029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monomeric G proteins AGS1 and Rhes selectively influence Galphai-dependent signaling to modulate N-type (CaV2.2) calcium channels.
    Thapliyal A; Bannister RA; Hanks C; Adams BA
    Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1417-26. PubMed ID: 18815223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cationic region of Rhes mediates its interactions with specific Gbeta subunits.
    Hill C; Goddard A; Ladds G; Davey J
    Cell Physiol Biochem; 2009; 23(1-3):1-8. PubMed ID: 19255495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.
    Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V
    Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route.
    Subramaniam S
    J Huntingtons Dis; 2022; 11(3):281-290. PubMed ID: 35871361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.
    Shahani N; Swarnkar S; Giovinazzo V; Morgenweck J; Bohn LM; Scharager-Tapia C; Pascal B; Martinez-Acedo P; Khare K; Subramaniam S
    Sci Signal; 2016 Nov; 9(454):ra111. PubMed ID: 27902448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum.
    Vargiu P; Morte B; Manzano J; Perez J; de Abajo R; Gregor Sutcliffe J; Bernal J
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):1-8. PubMed ID: 11597759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum).
    Subramaniam S; Snyder SH
    Neuropharmacology; 2011 Jun; 60(7-8):1187-92. PubMed ID: 21044641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes).
    Harrison LM; Lahoste GJ; Ruskin DN
    Brain Res; 2008 Dec; 1245():16-25. PubMed ID: 18929545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors.
    Vargiu P; De Abajo R; Garcia-Ranea JA; Valencia A; Santisteban P; Crespo P; Bernal J
    Oncogene; 2004 Jan; 23(2):559-68. PubMed ID: 14724584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.
    Lee JH; Tecedor L; Chen YH; Monteys AM; Sowada MJ; Thompson LM; Davidson BL
    Neuron; 2015 Jan; 85(2):303-15. PubMed ID: 25556834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhes suppression enhances disease phenotypes in Huntington's disease mice.
    Lee JH; Sowada MJ; Boudreau RL; Aerts AM; Thedens DR; Nopoulos P; Davidson BL
    J Huntingtons Dis; 2014; 3(1):65-71. PubMed ID: 25062765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKA modulates iron trafficking in the striatum via small GTPase, Rhes.
    Choi BR; Bang S; Chen Y; Cheah JH; Kim SF
    Neuroscience; 2013 Dec; 253():214-20. PubMed ID: 23999124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.
    Harrison LM; Muller SH; Spano D
    Neuroscience; 2013 Apr; 236():21-30. PubMed ID: 23380502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses.
    Napolitano F; De Rosa A; Russo R; Di Maio A; Garofalo M; Federici M; Migliarini S; Ledonne A; Rizzo FR; Avallone L; Nuzzo T; Biagini T; Pasqualetti M; Mercuri NB; Mazza T; Chambery A; Usiello A
    Sci Rep; 2019 Oct; 9(1):15294. PubMed ID: 31653935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.